We have just published our latest review about the role of KLK3 as an activator of VEGF-C and VEGF-D in prostate cancer. Prostate cancer is one of the most common cancers in males. It is not a question whether you will get it but only when.
Erich Brenner asked us more than a year ago whether we could contribute to Annals of Anatomy's special issue about human lymph vessels...